公众号 / 文章心血管MR

首过灌注与T1加权Dixon成像在 pericardial 疾病评估中的应用

First-Pass Perfusion and T1-weighted Dixon Imaging as Emerging Biomarkers of Pericardial Disease.
PubMed 文献 · Radiol Cardiothorac Imaging · 2026-01-01

本文为影像综述,阐述心脏MRI评估心包疾病的三支柱框架:解剖、功能与组织特征。重点介绍首过灌注与增强后T1加权Dixon两种序列的附加价值,旨在区分活动性炎症、慢性及非活动性心包疾病,使影像表现更贴合临床表型。

要点

  • 首过灌注反映微血管充血,有助于鉴别活动性与非活动性心包疾病。
  • T1加权Dixon可稳健抑脂,减少心包旁脂肪导致的增强误判。
  • 传统T2加权三反转恢复易受运动伪影影响,常规LGE可能高估心包强化。

核心结论

  • 首过灌注可显示早期对比剂摄取,反映微血管充血这一活动性炎症的生理标志,可能有助于区分活动性与非活动性疾病并支持临床决策。
  • 增强后T1加权Dixon成像通过化学位移重建实现稳健脂肪抑制,可提高心包强化的特异性,减少邻近脂肪组织引起的误读。

研究设计与样本

  • 本文为影像综述(imaging essay),未报告样本量、中心数、设备或参考标准。

关键影像表现/征象

  • 首过灌注可显示早期对比剂摄取,反映微血管充血,即活动性炎症的生理标志。
  • 首过灌注曾用于检测心肌炎中的心外膜下充血,但在心包评估中的潜在作用尚未充分探索。
  • T1加权Dixon通过化学位移重建提供稳健的脂肪抑制,可区分心包强化与相邻脂肪信号。
  • 常规非脂肪抑制的延迟钆增强图像可能因邻近心外膜和心包外脂肪而高估心包强化。

临床应用与阅片要点

  • 建议将首过灌注与增强后T1加权Dixon作为心包组织特征的补充序列,与解剖和功能评估相结合。
  • 使用T1加权Dixon替代或补充非脂肪抑制序列时,应警惕相邻脂肪假性强化陷阱。
  • 首过灌注结果应结合临床决策,用于区分活动性、慢性及非活动性(burned-out)心包疾病阶段。

局限性

  • T2加权三反转恢复序列易受运动伪影影响。
  • 常规非脂肪抑制的延迟钆增强图像可能因邻近脂肪而高估心包强化。
  • 首过灌注在心包评估中的潜在作用仍未被充分探索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Pericardial assessment with cardiac MRI relies on three complementary pillars: anatomic evaluation, functional characterization, and tissue characterization. Tissue characterization traditionally depends on T2-weighted triple inversion recovery imaging for helping to detect edema and late gadolinium enhancement for helping to identify inflammation or fibrosis. However, these techniques have important limitations, including the susceptibility of T2-weighted triple inversion recovery to motion artifacts and the potential overestimation of pericardial enhancement on conventional, non-fat-suppressed late gadolinium enhancement images due to adjacent epicardial and epipericardial fat. This imaging essay demonstrates the added value of two complementary and widely available sequences, first-pass perfusion and postcontrast T1-weighted Dixon, for pericardial tissue characterization. First-pass perfusion depicts early contrast media uptake which reflects microvascular hyperemia, a physiologic hallmark of active inflammation, and thus may help differentiate active from inactive disease and support clinical decision-making. Although previously applied to detect subepicardial hyperemia in myocarditis, the potential role of first-pass perfusion in pericardial evaluation remains incompletely explored. T1-weighted Dixon imaging provides robust fat suppression through chemical shift reconstruction, increasing the specificity of pericardial enhancement and reducing misinterpretation caused by adjacent adipose tissue. The aim of this imaging essay is to present the potential role of first-pass perfusion and T1-weighted Dixon imaging in improving pericardial tissue characterization and differentiating active inflammatory, chronic, and inactive ("burned-out") stages of pericardial disease, thereby aligning imaging findings more closely with clinically relevant phenotypes. Keywords: MR Imaging, MR Perfusion, Cardiac, Mediastinum, Pericardium Supplemental material is available for this article. © RSNA, 2026.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Vaz, Ramos, Crusoé, et al. First-Pass Perfusion and T1-weighted Dixon Imaging as Emerging Biomarkers of Pericardial Disease. Radiol Cardiothorac Imaging. 2026. PMID: 42658071. doi:10.1148/ryct.250565

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。